exsar.com

Manufacturing · 11-50 Employees

View Company Info for Free

Overview

Revenue

$11.4 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About exsar.com

Zywie LLC is a therapeutics company dedicated to addressing metabolic and neurodegenerative disorders classified as Lysosomal Storage Diseases (LSDs), tapping into a multi-billion dollar market. The company focuses on utilizing pharmacological chaperones (PCs), which are small molecules designed to aid in the proper folding and trafficking of misfolded proteins within cells. Their approach includes innovative treatments like deuterated and halogenated forms of Ambroxol, aimed at enhancing cellular autophagy to eliminate misfolded proteins. Zywie targets healthcare providers and researchers involved in the treatment of complex protein misfolding disorders.Explore more
exsar.com's Social MediaPopular SearchesSIC Code 28,283NAICS Code 32,325Show more

exsar.com Org Chart

PhoneEmail
EY

Research Associate

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is exsar.com your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Top Manufacturing Companies

Frequently Asked Questions Regarding exsar.com

What is exsar.com's official website?
exsar.com's official website is www.exsar.com
What is exsar.com's Revenue?
exsar.com's revenue is $11.4 Million
What is exsar.com's SIC code?
exsar.com's SIC: 28,283
What is exsar.com's NAICS code?
exsar.com's NAICS: 32,325
How many employees does exsar.com have?
exsar.com has 11-50 employees
What industry does exsar.com belong to?
exsar.com is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What does exsar.com do?

Zywie LLC is a therapeutics company dedicated to addressing metabolic and neurodegenerative disorders classified as Lysosomal Storage Diseases (LSDs), tapping into a multi-billion dollar market. The company focuses on utilizing pharmacological chaperones (PCs), which are small molecules designed to aid in the proper folding and trafficking of misfo... lded proteins within cells. Their approach includes innovative treatments like deuterated and halogenated forms of Ambroxol, aimed at enhancing cellular autophagy to eliminate misfolded proteins. Zywie targets healthcare providers and researchers involved in the treatment of complex protein misfolding disorders.Read More

What are exsar.com social media links?
exsar.com Linkedin page
Is exsar.com a public company?
exsar.com is private company therefore does not currently have an official ticker symbol
See more information about exsar.com

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.